.png){kind=icon}
.png){kind=icon}
Return
Architects of catch-up: a synergistic financial engine for China’s pharmaceutical industry
.png){kind=icon}
PRE
AI
Y
Q
H
DOI：10.1093/scipol/scag052.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
This paper investigates how China architected a mission-oriented financial policy mix to accelerate its catch-up in pharmaceutical innovation. It analyzes two national financial instruments and their synergistic linkage: the Major Project for Drug Innovation Program (MPDI) and the STAR Market’s Fifth Listing Standard. Using a mixed-methods approach combining quantitative analysis with interviews, the study demonstrates how these policies form a coherent ‘push-pull’ engine. The MPDI provides a top-down ‘R&D push’, setting national direction and de-risking early-stage science, while the STAR Market provides a bottom-up ‘capital pull’, enabling market-based selection and de-risking late-stage finance. This coordinated architecture offers a novel governance model for Mission-Oriented Innovation Policy, illustrating how a state can balance strategic direction with market dynamism and achieve cross-ministerial coordination to drive high-risk industrial transformation.
Journal
IF:
2.3
Papers:
180
Citations:
3.1K
Organization
Cited Papers